Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
2 other identifiers
interventional
189
1 country
1
Brief Summary
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping products to parents or health providers and instead turn to social media to share and seek out information regarding vaping risks and cessation supports. Thus, our current proposal outlines the use of social media to identify teens and young adults socially networking about vaping, the use of an online chatbot screen to evaluate individual cessation support needs, and the use of a digital intervention system to support vaping cessation. The mobile intervention used in this study is based on a widely-used evidence-based mobile intervention for combustible smoking (i.e., quitSTART) and has been adapted for vaping and young adults to include an in-app chatbot to guide users to tailored content and to motivate and encourage their cessation efforts. We aim to integrate our social media recruitment and online screening approach to connect individuals with this mobile app intervention, and will conduct a randomized controlled trial to evaluate user engagement with and preliminary efficacy of the digital intervention on reducing vaping behaviors among teens and young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2023
CompletedFirst Posted
Study publicly available on registry
August 16, 2023
CompletedStudy Start
First participant enrolled
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 13, 2026
April 1, 2026
1.6 years
August 8, 2023
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaping cessation
Vaping cessation as assessed by 7 day self-reported vaping abstinence at follow-up. Timeline follow back procedures will be used to establish abstinence or if participants lapsed (their first instance of vaping post quit) or relapsed (vaped on 7 consecutive days) at each follow up time point.
Baseline, 6 weeks, 3 months
Secondary Outcomes (3)
Nicotine dependence
Baseline, 6 weeks, 3 months
Risk perception related to vaping
Baseline, 6 weeks, 3 months
Intervention engagement
Baseline, 6 weeks, 3 months
Study Arms (3)
Control Group
NO INTERVENTIONNationwide resource referral and intervention waitlist
Experimental Group A: Mobile App Intervention
EXPERIMENTALquitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults
Experimental Group B: Mobile App Intervention with Embedded Chatbot Feature
EXPERIMENTALquitSTART Mobile Application Adapted for Vaping Cessation Among Young Adults Including Embedded Chatbot Feature
Interventions
Mobile application with educational content, motivational messages, self-monitoring, and tips for managing cravings to support vaping cessation among young adults.
In-App chatbot feature emedded into quitSTART mobile application to motivate vaping cessation and support app navigation.
Eligibility Criteria
You may qualify if:
- US Resident
- English Speaking
- Have daily access to a smartphone
- Current vaping product user (P30D)
- Identified as socially networking about a desire to quit vaping and/or experiencing negative health outcomes due to vaping
- Vaping product user only (i.e., not using vaping as a means to support combustible smoking cessation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University in St. Louis, School of Medicine
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2023
First Posted
August 16, 2023
Study Start
June 4, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04